The
dangers of diagnostic inflation in psychiatry
07
March 2012 Journal of Psychotherapy and
Psychosomatics
Alan
Frances, the coordinator of the official diagnostic classification in
psychiatry that was published in 1994 (DSM-IV), takes a very critical stand
against current developments of psychiatric classification in the current issue
of Psychotherapy and Psychosomatics.
There
are converging pressures on psychiatrists, primary care physicians, and other
mental health workers to over diagnose and over treat mental illness. The two
diagnostic systems in use worldwide are ICD-10 (published in 1992) and DSM-IV
(published in 1994 and very slightly revised in 2000). Their predecessors DSM-I
(published in 1952 in conjunction with ICD 6) and DSM-II (in 1968 with ICD 8A)
provided a broad based psychiatric classification that was likely to identify
significant rates of psychiatric disorder in the general population. However,
lacking any reliable method of psychiatric diagnosis, it was impossible to
ascertain just how high these rates might actually be.
Criterion-based
diagnosis was introduced as an innovative method to improve reliability, first
with the narrowly drawn Feighner criteria in 1972, then expanded in the
Research Diagnostic Criteria in 1975, and finally much expanded and made
official with the publication of DSM-III in 1980. DSM-III offered a common
clinical and research language that made it possible to study the prevalence of
mental disorders within the community. It was a splitter’s system with many
narrowly defined, high prevalence diagnoses. Not surprisingly, the introduction
of DSM-III resulted in a rum of diagnostic inflation that greatly expanded the
boundary of mental disorders at the expense of the shrinking province of
normality.
DSM-IV
took a conservative approach aimed at avoiding further exacerbation of
diagnostic inflation. Epidemiological studies show that the overall prevalence
of psychiatric disorders in adults stabilized. Nevertheless, DSM-IV was itself
a contributor to three false-positive ‘epidemics’: adult bipolar disorders,
attention deficit hyperactivity disorder, autistic disorder and childhood
bipolar disorder.
Unfortunately,
DSM-5, scheduled to appear in May 2013, proposes another grand expansion of
mental illness, with suggestions that taken together may create tens of
millions of additional new patients, all by arbitrary diagnostic fiat. It has
been subjected to withering (and much deserved) criticism in the international
press. Having lost faith in DSM 5 credibility, 47 mental health associations
have endorsed a petition requesting an independent scientific review. Constant
delays and disappointing results in its field testing guarantee that DSM 5 will
be rushed, radical, and reckless- with the potential to cause great harms to
individuals and to public policy. According to the Authors, all this will happen
in three ways.
First,
DSM-5 plans to introduce five new, high prevalence disorders at the populous
and fuzzy boundary with normality (mixed anxiety depression, binge eating, mild
neurocognitive, mood dysregulation, and attenuated psychotic symptoms). Second,
DSM-5 will reduce thresholds in the criteria sets of very common disorders in a
way that may make them much more common (especially generalized anxiety and
adult attention deficit). Finally, creating spectrums of autism and addictions
will likely broaden their purview. The DSM-5 principle has been to avoid false
negatives at all costs and to worry not at all about false positives. In
contrast, the Authors believe the false positive problem in psychiatric
diagnosis is now far worse than the false negative problem. Certainly many
severely suffering potential patients do not get the treatment they could
clearly benefit from, but this is not due to diagnostic thresholds being set
too high and it will not be corrected by creating new and unproven mild boundary
disorders. On the other hand, false-positive diagnoses create huge and obvious
problems: unnecessary, harmful, and expensive treatments; stigma; lowered
expectations and a reduced sense of personal responsibility; misallocation of
resources from the really ill to the worried well; difficulties getting
insurance; excessive disability; forensic complications, and more.
Stepped
diagnosis and treatment are based on a model of health care delivery in which
the first-line efforts are the least intensive of those available that are
still likely to provide a significant health gain. More definitive diagnoses
and expensive treatments are preserved for people who are not able to benefit
from the simpler, stepped, first-line interventions. Continuous assessments of
the patient’s condition are crucial – with timely ‘stepping up’ if a lesser
intervention is not achieving a significant health gain. Stepped care starts
with a stepped diagnosis. Prior to a definitive diagnosis, the primary care
doctor or mental health professional takes the following steps:
(1)
Gather baseline data. For moderate and severe problems go directly to step 6.
For mild, first-onset, and/or stress reactive problems continue to the next
step. (2) Normalize problems without devaluing or minimizing the patient’s pain
or distress. Reassure the patient that his or her emotions are an expectable
response to the stressors in his or her life. Speak in terms of ‘problems’ or
‘difficulties’, actively avoid terms like ‘depression’ or ‘psychiatric illness’.
(3) Watchful waiting – a period of continued assessment, monitoring, and
scheduled follow-up with no pretence of a definitive diagnosis or active
treatment. (4) Minimal interventions aimed at stress reduction, such as
bibliotherapy or computer-aided therapy. Make explicit that these are not
offered to treat a psychiatric disorder that has already been defined. A major
advantage of these minimal interventions is that they harness the person’s
capacity for self-help as much as possible . (5) Brief counseling – simple
techniques derived from cognitive behavior therapy, problem solving therapy, or
solution-focused brief therapy to teach new attitudes and coping skills in
dealing with stressors. (6) The definitive diagnosis is made and definitive
treatment is begun whenever symptoms persist to cause clinically significant
distress or impairment.
Although
step 6 and further is beyond the scope of this paper, the Authors think it is
important to stress that the process of (pre)diagnostic reasoning does not end
with a DSM diagnosis and pharmaceutical treatment. A DSM diagnosis should be
the beginning of a diagnostic process and individualized treatment in which
psychotherapeutic interventions may follow pharmacological treatment and vice
versa.
Stepped
diagnosis is a tool to help physicians and mental health workers make more
accurate diagnoses and to reduce the provision of unnecessary and possibly
harmful treatment. It is intended to reduce false-positive diagnoses and
consequential artificially elevated rates of mental illness without risking
missed diagnosis and under treatment. It should also improve the allocation of
resources by redirecting diagnosis and care away from those who do not really
need them towards those who really do. Mild psychiatric presentations often
resolve with the passage of time, placebo effect, and minor interventions. It
is cost and stigma saving to adequately reimburse careful evaluations as a
means of reducing overdiagnosis and avoiding unnecessarily intensive
treatments.
Psychiatry
can enhance its credibility and improve its results by sticking to its
appropriate target population of the moderately and severely ill. Stepped
diagnosis will keep the worried well from being mislabeled as mentally
disordered.
- Full bibliographic informationBatstra, L. ; Frances, A. Holding the Line against Diagnostic Inflation in Psychiatry. Psychother Psychosom 2012;81:5-10
No comments:
Post a Comment
PLEASE ADD COMMENTS SO I CAN IMPROVE THE INFORMATION I AM SHARING ON THIS VERY IMPORTANT TOPIC.